RBC Capital Maintains Sector Perform on aTyr Pharma, Lowers Price Target to $6

Benzinga · 3d ago
RBC Capital analyst Brian Abrahams maintains aTyr Pharma (NASDAQ:ATYR) with a Sector Perform and lowers the price target from $40 to $6.